Is Pacific race a retinopathy of prematurity risk factor?

Archives of Pediatrics and Adolescent Medicine

Volumn 159, Issue 8, 2005, Pages 771-773

  Lang, Dustin M ^a   Blackledge, Jon ^b   Arnold, Robert W ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Ophthalmic Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; ASIAN; AUTUMN; BIRTH WEIGHT; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DOCUMENTATION; GESTATIONAL AGE; HUMAN; INFANT; INFANT DISEASE; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; MOTHER CHILD RELATION; NEWBORN INTENSIVE CARE; PRENATAL CARE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RETINA BLOOD VESSEL; RETINA DETACHMENT; RETROLENTAL FIBROPLASIA; RISK ASSESSMENT; RISK FACTOR; SUMMER; TREATMENT INDICATION; UNITED STATES;

ALASKA; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INUITS; MALE; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RETINOPATHY OF PREMATURITY; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; TIME FACTORS;

EID: 23744513886     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.159.8.771     Document Type: Article

References (15)

1. Palmer EA, Flynn JT, Hardy RJ, et al; Cryotherapy for Retinopathy of Prematurity Cooperative Group. Incidence and early course of retinopathy of prematurity. Ophthalmology. 1991;98:1628-1640.
2. Brown BA, Thach AB, Song JC, Marx JL, Kwun RC, Frambach DA. Retinopathy of prematurity: evaluation of risk factors. Int Ophthalmol. 1998;22:279-283.
3. Tadesse M, Dhanireddy R, Mittal M, Higgins RD. Race, Candida sepsis, and retinopathy of prematurity. Biol Neonate. 2002;81:86-90.
4. Saunders RA, Donahue ML, Christmann LM, et al; Cryotherapy for Retinopathy of Prematurity Cooperative Group. Racial variation in retinopathy of prematurity. Arch Ophthalmol. 1997;115:604-608.
5. Monos T, Rosen S, Karplus M, Yassur Y. Fundus pigmentation in retinopathy of prematurity. Pediatrics. 1996;97:343-348.
6. Schaffer DB, Palmer EA, Plotsky DF, et al; Cryotherapy for Retinopathy of Prematurity Cooperative Group. Prognostic factors in the natural course of retinopathy of prematurity. Ophthalmology. 1993;100:230-237.
7. Arnold R, Kesler K, Avila E. Susceptibility to ROP in Alaskan natives. J Pediatr Ophthalmol Strabismus. 1994;31:192-194.
8. Osborne NG, Feit MD. The use of race in medical research. JAMA. 1992;267:275-279.
9. Chow LC, Wright KW, Sola A; CSMC Oxygen Administration Study Group. Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics. 2003;111:339-345.
10. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the Early Treatment for Retinopathy of Prematurity randomized trial. Arch Ophthalmol. 2003;121:1684-1694.
11. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), a randomized, controlled trial, I: primary outcomes. Pediatrics. 2000;105:295-310.
12. Parfit M. Dawn of humans. Natl Geogr Mag. 2000;198:40-67.
13. Gao G, Li Y, Fant J, Crosson CE, Becerra SP, Ma JX. Difference in ischemic regulation of vascular endothelial growth factor and pigment epithelium-derived factor in Brown Norway and Sprague Dawley rats contributing to different susceptibilities to retinal neovascularization. Diabetes. 2002;51:1218-1225.
14. Dorfman A, Joly S, Moukhles H, Chemtob S, Lachapelle P. Rats are not all created equal when dealing with postnatal hyperoxia. Paper presented at: Third International Symposium on ROP: An Update on ROP From the Lab to the Nursery; November 13, 2003; Anaheim, Calif.
15. Steinkuller PG, Du L, Gilbert C, Foster A, Collins ML, Coats DK. Childhood blindness. J AAPOS. 1999;3:26-32.